GUIDED THERAPEUTICS, INC.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 11, 2008 (December 10, 2008)

GUIDED THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)		 0-22179
(Commission File Number) 		58-2029543
(IRS Employer Identification No.)
 

4955 Avalon Ridge Pkwy, Suite 300
Norcross, Georgia
(Address of Principal Executive Offices)

 30071
(Zip Code)

Registrant's Telephone Number, Including Area Code:     (770) 242-8723

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 

TABLE OF CONTENTS

Item 8.01. Other Events.
 

Item 9.01. Financial Statements and Exhibits.
Exhibit Index
Exhibit 99.1
SIGNATURES

Table of Contents

Item 8.01.          Other Events.

On December 10, 2008, Guided Therapeutics, Inc. reported that the Company had submitted the first of three modules of its Premarket Approval application with the United State Food and Drug Administration for the company's LightTouch(tm) Non-invasive Cervical Cancer Detection Device as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto and which information is incorporated herein by reference.

Table of Contents

Item 9.01.       Financial Statements and Exhibits.

           (d)        Exhibits.
            The following exhibits are filed with this report:

 

Exhibit No.

Exhibit Description

99.1

Press Release, dated December 10, 2008

 

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    GUIDED THERAPEUTICS, INC.
 
   
/s/ MARK L. FAUPEL
    By:   Mark L. Faupel, Ph.D.
        CEO & President
 
Date: December 11, 2008